LaColla; Paola

Patent Applications and Registrations

Patent applications and USPTO patent grants for LaColla; Paola.The latest application filed is for "2' and 3'-nucleoside prodrugs for treating flaviviridae infections".

Company Profile

0.8.17

LaColla; Paola - Capoterra IT
LaColla; Paola - Cagliari IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,662,798 - LaColla , et al. February 16, 2	2010-02-16
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,635,689 - LaColla , et al. December 22, 2	2009-12-22
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,625,875 - Gosselin , et al. December 1, 2	2009-12-01
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,608,600 - Storer , et al. October 27, 2	2009-10-27
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,547,704 - LaColla , et al. June 16, 2	2009-06-16
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,384,924 - LaColla , et al. June 10, 2	2008-06-10
Modified 2' and 3'-nucleoside prodrugs for treating Flavivridae infections Grant 7,365,057 - LaColla , et al. April 29, 2	2008-04-29
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,192,936 - LaColla , et al. March 20, 2	2007-03-20
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070060503 - Gosselin; Gilles ; et al.	2007-03-15
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070060541 - Gosselin; Gilles ; et al.	2007-03-15
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070060505 - Gosselin; Gilles ; et al.	2007-03-15
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070060504 - Gosselin; Gilles ; et al.	2007-03-15
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070060498 - Gosselin; Gilles ; et al.	2007-03-15
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070042990 - Gosselin; Gilles ; et al.	2007-02-22
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections App 20070042939 - LaColla; Paola ; et al.	2007-02-22
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections App 20070042940 - LaColla; Paola ; et al.	2007-02-22
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections App 20070042991 - LaColla; Paola ; et al.	2007-02-22
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070037735 - Gosselin; Gilles ; et al.	2007-02-15
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections App 20070032449 - LaColla; Paola ; et al.	2007-02-08
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections App 20070032407 - LaColla; Paola ; et al.	2007-02-08
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070027066 - LaColla; Paola ; et al.	2007-02-01
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070027104 - LaColla; Paola ; et al.	2007-02-01
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070027065 - LaColla; Paola ; et al.	2007-02-01
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections App 20070015905 - LaColla; Paola ; et al.	2007-01-18
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections App 20040077587 - Sommadossi, Jean-Pierre ; et al.	2004-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.